Key Record Dates
ClinicalTrials.gov Identifier: | NCT05091424 |
---|---|
Brief Title: | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia |
First Submitted : | October 12, 2021 |
First Submitted that Met QC Criteria : | October 12, 2021 |
First Posted : | October 25, 2021 |
Last Update Submitted that Met QC Criteria : | May 3, 2023 |
Last Update Posted : | May 6, 2023 |